Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.

2.

Advanced breast cancer patients living longer thanks to improvements in treatment and care

3.

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

4.

How wildfires pose challenges to cancer care

5.

New research uncovers link between cancer pathway and blood-retina barrier function


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot